Nearly half of the unrelated hematopoietic SCTs facilitated worldwide involves an exchange of products between countries. The process is information intensive and requires coordination through regional hubs of complex data transactions of demographic, clinical and genetic information, laboratory samples and results. Each registry has developed its own unique systems for representing data and process leading to transplantation. The WMDA Information Technology Working Group was formed in the autumn of 2001 as a forum to discuss and develop standards for information technology (IT) in support of hematopoietic stem cell registries. Its membership includes experts in IT from the WMDA member registries. The group has focused its standardization efforts on three areas:
HLA; matching; standards; hematopoietic stem cell Standard reference data sets: HLA nomenclature Electronic data exchange for search information as well as for requesting and providing subsequent services has an ever-increasing role in national and international searches for unrelated volunteer donors of hematopoietic progenitor cells. To eliminate errors, ambiguities and incompatibilities in the transmission of HLA data between stem cell donor registries and cord blood banks, the Information Technology and Quality Assurance Working Groups of the WMDA have developed guidelines for the nomenclature of HLA typing assignments. 1 These guidelines are firmly based on the nomenclature developed by the World Health Organisation Nomenclature Committee for factors of the HLA System 2 and uniformly accepted by the HLA community and on the requirements for presenting and condensing HLA data within the format of the registries' information systems.
The WMDA HLA guidelines consist of a set of welldefined rules describing how a valid phenotype and a valid typing result may be presented with regard to the structure and contents of individual data fields and cross-checks applied between given fields. For the information technology (IT) specialists, these rules can be regarded as a specification of a validation routine to be applied to all incoming HLA data. Such a routine might include review for valid letter codes and basic rules for assignments and cross-checks between serological and allelic assignments for HLA.
The NMDP (http://bioinformatics.nmdp.org/HLA/ Allele_Codes/Allele_Code_Lists/index.html) allele code system was developed to provide a standard shorthand for reporting lists of possible alleles (for example, DRB1*01AD ¼ DRB1*0101 or DRB1*0104). Owing to the vast polymorphism of HLA and the need for compact representation of ambiguities, there have been over 65 000 of these alphabetical codes defined. With 50-100 of these codes created in a typical day, it is critical for global communication between registries to use an up-to-date shared reference for this sort of information.
In the course of the standardization of the electronic exchange of HLA data, two reference web sites (http:// hla.alleles.org/wmda/index.html and http://hla.alleles.org/ nomenclature/nomenclature_2009.html) 3 have been designated to maintain and update the approved HLA nomenclature and all the ancillary information needed by the conventions of the guidelines. In addition, a compre-hensive low-level software library providing a large set of elementary HLA functions has been developed for programmers creating software for the provider chain from laboratory to donor centers, registries and transplant centers. 4 In response to the continuing increase in the number HLA alleles described, it has become necessary to introduce a new nomenclature for HLA (http://hla.alleles.org/nomenclature/nomenclature_2009.html). Instead of a numeric string for each allele, this new nomenclature will introduce colons (:) into the allele names to act as a delimiter for separate fields. These separate fields will now be explicitly described and can expand beyond the current limitation of the position-based nomenclature. For example, alleles in the B*35 family are named B*3501, B*3502, B*3503, and so on. When the 100th allele in this family is described, it will require expansion of the allele number beyond (for example, B*35:100). Figure 1 shows how the overflow in allele names will be addressed.
Full HLA nomenclature currently represents alleles with eight digits. The first two digits describe the allele family, which often corresponds to the serological antigen carried by the allotype. The third and fourth digits are assigned in the order in which the sequences have been determined. Alleles whose numbers differ in the first four digits must differ in one or more nucleotide substitutions that change the amino-acid sequence of the encoded protein. Alleles that differ only by synonymous nucleotide substitutions within the coding sequence are distinguished by the use of the fifth and sixth digits. Alleles that only differ by sequence polymorphisms in introns or in the 5 0 and 3 0 untranslated regions that flank the exons and introns are distinguished by the use of the seventh and eighth digits. As all four of these fields are facing overflow, the new nomenclature extends to the complete allele names; for example, A*01010101 becomes A*01:01:01:01 ( Figure 2 ).
Matching algorithm standards
One of the most complicated components of a registry IT system is the matching algorithm. The goal of this algorithm is to identify volunteers or cord blood units (CBU) that express the same histocompatibility antigens as a searching patient. HLA data are very complex and registries are heterogeneous in terms of the HLA loci typed, the typing resolution and typing methodologies used. These data are collected over many years as technologies change and improve, and yet must be evaluated in a comprehensive and consistent way.
The objective of a registry matching algorithm is rapid retrieval of appropriately matched donor and/or CBU candidates from a large database, most likely to serve as a hematopoietic stem cell source for the patient. The selection and sorting criteria is based on general principles and may also consider the transplant protocol and the overall demographics of stem cell donors and/or CBUs. The matching algorithm is usually developed with the aid of local HLA expertise and can encode local assumptions about how to describe matches, potential matches, mismatches and mappings between HLA types ascertained using different methods (serologic, DNA-based), which can lead to variation between systems. This variation can confound global searches because the results of different algorithms are often not comparable.
We have developed two strategies for providing standardization of registry matching algorithms. The first is a high-level approach, which is a formal specification of matching using rigorous terminology. The second is an approach to standardization in which the results of matching systems are compared based on a standard set of reference data sets.
Formal HLA-matching specification
To aid both newly created and existing donor registries around the world to review and validate the most critical part of their IT systems, the Information Technology Working Group (ITWG) of the WMDA has compiled a comprehensive framework for the implementation of HLAmatching programs. This logically rigorous approach starts with the comparison of individual HLA markers of the patient and the potential donors and inductively builds up the more complex matching of single-and multilocus phenotypes. The challenging coexistence of the serological and allelic HLA nomenclature at various typing resolutions caused by the use of different typing methodologies is addressed explicitly. 1 The consensus of this international collaborative work describes the state of the art in this field and highlights many important design options compatible with the best practice. Furthermore, for the first time, a Information technology and the role of WMDA M Maiers et al common terminology of serological and allelic matching categories has been defined.
Matching algorithm cross-validation
A complementary approach to standardizing matching involves the implementation of a set of validation data sets of patients, donors and CBUs, which can be used to compare the output of multiple matching algorithms. This approach can highlight differences between algorithms that might not be detected based on a high-level description of the functional components and assumptions. The first, intentionally simple, version of the WMDA Matching Validation Set was developed in November 2006 with 10 000 donors, 100 000 cords and 1000 recipients, generated from real high-resolution phenotypes containing only DNA data of mixed resolution. In the next round, serological types were included and the 'true' genotypes were stored. The results format has been standardized to provide the number of antigen and allele matches per locus and a sum of matches. This standardized output has allowed discrepancies to be identified and categorized for further review and group discussion.
So far, comparison of the results from five participating registries has highlighted numerous differences in serology to DNA-mapping tables particularly in the context of genotypes that are ambiguous at the allelic level. In addition, varying assumptions for how to deal with changes in nomenclature over time (for example, deleted alleles) have manifested in variation between registries in matching results. These differences can now be addressed with more stringent standards in these two areas.
This is an ongoing activity of the WMDA IT Working Group and we are working toward the ultimate goal of providing certification (accreditation) of matching systems.
Naming conventions for identifiers and centers
The activity of hematopoietic stem cell registries depends greatly on the ability, uniquely and unambiguously, to identify individuals and stem cell products while maintaining a constant level of confidentiality. The use of unique identifiers (IDs) is commonplace; however, the community currently lacks a consistent global standard. This continues to be the source of confusion and ambiguity in the facilitation of global stem cell search. To remedy this situation, a global ID system is under development, which in turn rests on the foundation of a global registry/center naming system. This system has been a challenge to develop because of the competing needs of making it simple to adopt (for example, not requiring modification of existing local ID systems) and yet comprehensive and globally adopted. In the case of registry/center naming system, there is a need to be comprehensive and have low barriers for entry, which excludes some existing systems such as ISBT FIN (http:// www.iccbba.org), which involves a registration fee, and more importantly refers to harvesting centers but are not suitable for identifying registries and donor centers. The aim of EMDIS is to establish a single virtual international donor registry allowing search coordinators to get the same information and services on international donors as accurately, timely and easily as from their own national donors. The scope of operation covers all aspects of an unrelated donor search from the preliminary search to the donor workup. Technically, EMDIS defines an open specification of a protocol for the electronic communication among registries. Hence, EMDIS is implemented as an asynchronous peer-to-peer network connecting distributed, heterogeneous databases. 7, 8 Membership of EMDIS is free of charge. The community provides documentation, status information, software tools, support and a project management platform. 5, 9, 10 Federation of data: BMDW The BMDW 6 is a voluntary collaborative effort of stem cell donor registries and cord blood banks whose goal is to provide centralized information on the HLA phenotypes and other relevant data of unrelated stem cell donors and CBUs, and to make this information easily accessible to the physicians of patients in need of a hematopoietic stem cell transplant.
The BMDW started as an initiative of the Immunobiology Working Party of the European Group of Blood and Marrow Transplantation (EBMT) in 1988. In February 1989, the first edition was distributed, which contained the donor files of eight registries with a total of 155 000 volunteer stem cell donors. Currently (August 2009), there are 63 stem cell donor registries from 44 countries, and 43 organizations representing a single cord blood bank or a network of cord blood banks from 26 countries Almost all members of BMDW are also members of WMDA. Because of the shared membership and shared interests, BMDW is actively participating in the ITWG projects. A representative of the ITWG also participates in the BMDW Advisory Committee meeting, which strengthens both organizations.
Conclusion
In the future the registry community will face new challenges in adopting emerging data and security standards for health-care informatics. In particular, it is important that we enforce rigorous standards for genetic data representation as we enter this new era of genomic medicine.
